Eciruciclib
CAS No. 1868086-40-1
Eciruciclib ( —— )
Catalog No. M28496 CAS No. 1868086-40-1
Eciruciclib is an inhibitor of CDK with antitumor properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 312 | Get Quote |
|
10MG | 500 | Get Quote |
|
25MG | 807 | Get Quote |
|
50MG | 1107 | Get Quote |
|
100MG | 1485 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEciruciclib
-
NoteResearch use only, not for human use.
-
Brief DescriptionEciruciclib is an inhibitor of CDK with antitumor properties.
-
DescriptionEciruciclib is an inhibitor of CDK with antitumor properties.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1868086-40-1
-
Formula Weight488.6
-
Molecular FormulaC27H33FN8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C1=C2C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=CC2=NN1C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
LY2857785
LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).
-
ON-013100
ON-013100 is an antineoplastic drug. ON-013100 also acts as a mitotic inhibitor that could inhibit Cyclin D1 expression.
-
SB415286
SB415286 is a potent GSK3α inhibitor with IC50/Ki of 78 nM/31 nM with equally effective inhibition of GSK-3β.